Involvement of ZIP/p62 in the regulation of PPARα transcriptional activity by p38-MAPK

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1781, Issue 5, 2008, Pages 239-244

  Diradourian, Claire ^a,b   Le May, Cédric ^a,b   Caüzac, Michèle ^a,b   Girard, Jean ^a,b   Burnol, Anne Françoise ^a,b   Pégorier, Jean Paul ^a,b  

^a INSTITUT COCHIN   (France)

^b INSERM   (France)

Author keywords

Anisomycin; Co immunoprecipitation; Hepatoma cell; L CPTI; p38 MAPK; Phosphorylation; PPAR ; Reporter gene; siRNA; ZIP p62

Indexed keywords

ANISOMYCIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN P62; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION;

ANIMALS; ANISOMYCIN; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEAT-SHOCK PROTEINS; MAP KINASE SIGNALING SYSTEM; NUCLEIC ACID SYNTHESIS INHIBITORS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PPAR ALPHA; PROTEIN KINASE C; RATS; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC;

EID: 43149088023     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2008.02.002     Document Type: Article

References (37)

1. Braissant O., Foufelle F., Scotto C., Dauça M., and Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-a, -ß and -g in the adult rat. Endocrinology 137 (1996) 354-366
2. Pawar A., and Jump D.B. Unsaturated fatty acid regulation of peroxisome proliferator-activated receptor alpha activity in rat primary hepatocytes. J. Biol. Chem. 278 (2003) 35931-35939
3. Devchand P.R., Keller H., Peters J.M., Vazquez M., Gonzalez F.J., and Wahli W. The PPAR alpha-leukotriene B4 pathway to inflammation control. Nature 384 (1996) 39-43
4. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20 (1999) 649-688
5. Rochette-Egly C. Nuclear receptors: integration of multiple signalling pathways through phosphorylation. Cell. Signal. 15 (2003) 355-366
6. Diradourian C., Girard J., and Pégorier J.P. Phosphorylation of PPARs: from molecular characterization to physiological relevance. Biochimie 87 (2005) 33-38
7. Burns K.A., and Vanden Heuvel J.P. Modulation of PPAR activity via phosphorylation. Biochim. Biophys. Acta 1771 (2007) 952-960
8. Juge-Aubry C.E., Hammar E., Siegrist-Kaiser C., Pernin A., Takeshita A., Chin W.W., Burger A.G., and Meier C.A. Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor a by phosphorylation of a ligand-independent trans-activating domain. J. Biol. Chem. 274 (1999) 10505-10510
9. Lazennec G., Canaple L., Saugy D., and Wahli W. Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol. Endocrinol. 14 (2000) 1962-1975
10. Blanquart C., Mansouri R., Paumelle R., Fruchart J.C., Staels B., and Glineur C. The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha. Mol. Endocrinol. 18 (2004) 1906-1918
11. Barger P.M., Browning A.C., Garner A.N., and Kelly D.P. p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor a. A potential role in the cardiac metabolic stress response. J. Biol. Chem. 276 (2001) 44495-44501
12. Barger P.M., Brandt J.M., Leone T.C., Weinheimer C.J., and Kell D.P. Deactivation of peroxisome proliferator-activated receptor a during cardiac hypertrophic growth. J. Clin. Invest. 105 (2000) 1723-1730
13. Sudo T., Maruyama M., and Osada H. p62 functions as a p38 MAP kinase regulator. Biochem. Biophys. Res. Commun. 269 (2000) 521-525
14. Kasus-Jacobi A., Bereziat V., Perdereau D., Girard J., and Burnol A.F. Evidence for an interaction between the insulin receptor and Grb7. A role for two of its binding domains, PIR and SH2. Oncogene 19 (2000) 2052-2059
15. Le May C., Caüzac M., Diradourian C., Perdereau D., Girard J., Burnol A.F., and Pégorier J.P. Fatty acids induce L-CPT I gene expression through a PPARa-independent mechanism in rat hepatoma cells. J. Nutr. 135 (2005) 2313-2319
16. Bardot O., Aldridge T.C., Latruffe N., and Green S. PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem. Biophys. Res. Com. 1 (1993) 37-45
17. Ge B., Gram H., Di Padova F., Huang B., New L., Ulevitch R.J., Luo Y., and Han J. MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha. Science 295 (2002) 1291-1294
18. Cariou B., Perdereau D., Cailliau K., Browaeys-Poly E., Bereziat V., Vasseur-Cognet M., Girard J., and Burnol A.F. The adapter protein ZIP binds Grb14 and regulates its inhibitory action on insulin signaling by recruiting protein kinase Czeta. Mol. Cell. Biol. 22 (2002) 6959-6970
19. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., and Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci (U. S. A.) 92 (1995) 7297-7301
20. Louet J.F., Chatelain F., Decaux J.F., Park E.D., Kohl C., Pineau T., Girard J., and Pégorier J.P. Long-chain fatty acids regulate liver carnitine palmitoyltransferase I (L-CPT I)gene expression through a PPARa-independent pathway. Biochem. J. 354 (2001) 189-197
21. Dentin R., Pegorier J.P., Benhamed F., Foufelle F., Ferre P., Fauveau V., Magnuson M.A., Girard J., and Postic C. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J. Biol. Chem. 279 (2004) 20314-20326
22. Prip-Buus C., Cohen I., Kohl C., Esser V., McGarry J.D., and Girard J. Topological and functional analysis of the rat liver carnitine palmitoyltransferase 1 expressed in Saccharomyces cerevisiae. FEBS Lett. 429 (1998) 173-178
23. Shalev A., Siegrist-Kaiser C.A., Yen P.M., Wahli W., Burger A.G., Chin W.W., and Meier C.A. The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. Endocrinology 137 (1996) 4499-4502
24. Chatelain F., Kohl C., Esser V., McGarry J.D., Girard J., and Pégorier J.P. Cyclic AMP and fatty acids increase carnitine palmitoyltransferase I transcription in cultured fetal rat hepatocytes. Eur. J. Biochem. 235 (1996) 789-798
25. Geetha T., and Wooten M.W. Structure and functional properties of the ubiquitin binding protein p62. FEBS Lett. 512 (2002) 19-24
26. Puls A., Schmidt S., Grawe F., and Stabel S. Interaction of protein kinase C zeta with ZIP, a novel protein kinase C-binding protein. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 6191-6196
27. Sanz L., Diaz-Meco M.T., Nakano H., and Moscat J. The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway. EMBO J. 19 (2000) 1576-1586
28. Camp H.S., Tafuri S.R., and Leff T. c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity. Endocrinology 140 (1999) 392-397
29. Hu E., Kim J.B., Sarraf P., and Spiegelman B.M. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARg. Science 274 (1996) 2100-2103
30. Rangwala S.M., Rhoades B., Shapiro J.S., Rich A.S., Kim J.K., Shulman G.I., Kaestner K.H., and Lazar M.A. Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity. Dev. Cell 5 (2003) 657-663
31. Teruel T., Hernandez R., Benito M., and Lorenzo M. Rosiglitazone and retinoic acid induce uncoupling protein-1 in a p38 mitogen activated protein kinase dependent manner in fetal primary brown adipocytes. J. Biol. Chem. 278 (2003) 263-269
32. Schieven G.L. The biology of p38 kinase: a central role in inflammation. Curr. Top. Med. Chem. 5 (2005) 921-928
33. Rodriguez A., Duran A., Selloum M., Champy M.F., Diez-Guerra F.J., Flores J.M., Serrano M., Auwerx J., Diaz-Meco M.T., and Moscat J. Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. Cell. Metab. 3 (2006) 211-222
34. Sanz L., Sanchez P., Lallena M.J., Diaz-Meco M.T., and Moscat J. The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation. EMBO J. 18 (1999) 3044-3053
35. Lavinsky R.M., Jepsen K., Heinzel T., Torchia J., Mullen T.M., Schiff R., Del-Rio A.L., Ricote M., Ngo S., Gemsch J., Hilsenbeck S.G., Osborne C.K., Glass C.K., Rosenfeld M.G., and Rose D.W. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 2920-2925
36. Blanquart C., Barbier O., Fruchart J.C., Staels B., and Glineur C. Peroxisome proliferator-activated receptor alpha (PPARalpha) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes. J. Biol. Chem. 277 (2002) 37254-37259
37. Zatloukal K., Stumptner C., Fuchsbichler A., Heid H., Schnoelzer M., Kenner L., Kleinert R., Prinz M., Aguzzi A., and Denk H. p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am. J. Pathol. 160 (2002) 255-263